Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial gene expression machinery** comprises the network of molecular components responsible for transcription and translation in bacteria. At its core are **RNA polymerase** (responsible for synthesizing RNA from DNA) and the **ribosome** (responsible for synthesizing proteins from mRNA)[1][5][7]. Transcription and translation are tightly coupled processes in bacteria—often occurring concurrently within the cytoplasm—due to the short half-life of bacterial mRNA[1][3]. Key steps include: - Transcription initiation, controlled by *sigma factors* - RNA synthesis by RNA polymerase - mRNA processing (minimal in bacteria) - Translation on 70S ribosomes, which consists of a 30S (small) and 50S (large) subunit; ribosomal RNA (rRNA, such as 16S, 23S, 5S) and ribosomal proteins form these subunits[1][5] - Translation initiation starts at the first AUG codon after the *Shine-Dalgarno* sequence[5] - Translation involves initiation, elongation, termination, and ribosome recycling Gene expression is regulated through promoter elements, transcription factors, regulatory RNAs (e.g., sRNA, tmRNA), and various protein factors that modulate transcription and translation efficiency[1][2][3][6]. This machinery is a therapeutic target for numerous antibiotics that inhibit bacterial growth by interfering with transcription or translation[5][7]. However, the specificity and complexity of this network mean that broad targeting may be challenging, and the term "bacterial gene expression machinery" refers to a collection of targets rather than a specific molecule; for structured drug discovery, more specific targets (e.g., "Bacterial RNA polymerase", "Bacterial ribosome") are preferred. Note: The name "Bacterial gene expression machinery" is **overly broad**; it is a functional network (including multiple molecular targets, such as RNA polymerase, ribosome, sigma factors) rather than a canonical protein or receptor, and thus, care should be taken to specify individual target molecules for structured pharmacological analysis.
Inhibition of RNA polymerase activity (prevents transcription)[1][7]; Blocking ribosomal function (inhibits translation initiation or elongation)[1][5]; Disrupting transcription/translation coupling; Inhibiting bacterial protein synthesis by binding ribosomal subunits[5]; Interfering with mRNA or tRNA processing and stability
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial gene expression machinery.